trending Market Intelligence /marketintelligence/en/news-insights/trending/1qF9Y135H15PBnvL5SLHmQ2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

BioTime closes $28.8M common stock offering

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


BioTime closes $28.8M common stock offering

BioTime Inc. closed its public offering of 9,615,385 common shares at $2.60 apiece with gross proceeds of about $28.8 million.

The share sale includes 1,442,308 shares sold pursuant to the underwriters exercising their option to buy additional shares.

BioTime intends to use the net proceeds from the offering for general corporate purposes, including, without limitation, to fund clinical trials, research and development activities and for general working capital.

Raymond James & Associates Inc. acted as the sole book-running manager for the offering. Ladenburg Thalmann & Co. Inc., Chardan and LifeSci Capital LLC acted as co-managers. Lake Street Capital Markets acted as a financial adviser for the offering.